Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1964 2
1967 1
1969 2
1971 1
1972 1
1973 1
1974 3
1975 5
1976 5
1977 9
1978 9
1979 7
1980 8
1981 6
1982 7
1983 9
1984 6
1985 6
1986 9
1987 9
1988 5
1989 13
1990 9
1991 10
1992 7
1993 9
1994 11
1995 9
1996 13
1997 26
1998 22
1999 24
2000 24
2001 27
2002 26
2003 26
2004 40
2005 31
2006 48
2007 30
2008 43
2009 41
2010 34
2011 60
2012 50
2013 68
2014 75
2015 83
2016 84
2017 83
2018 104
2019 124
2020 147
2021 155
2022 170
2023 106
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

1,750 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma"
Page 1
Glaucoma.
Kang JM, Tanna AP. Kang JM, et al. Med Clin North Am. 2021 May;105(3):493-510. doi: 10.1016/j.mcna.2021.01.004. Epub 2021 Apr 2. Med Clin North Am. 2021. PMID: 33926643 Review.
Glaucoma is the leading cause of irreversible blindness worldwide. The global prevalence of glaucoma in people aged 40 to 80 years is estimated to be 3.5%. With the growing number and proportion of older persons in the population, it is projected that 111.8 million …
Glaucoma is the leading cause of irreversible blindness worldwide. The global prevalence of glaucoma in people aged 40 to 80 y …
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Adeleke M, Vickerstaff V, Ambler G, Hunter R, Bunce C, Nathwani N, Barton K; LiGHT Trial Study Group. Gazzard G, et al. Ophthalmology. 2023 Feb;130(2):139-151. doi: 10.1016/j.ophtha.2022.09.009. Epub 2022 Sep 17. Ophthalmology. 2023. PMID: 36122660 Free article. Clinical Trial.
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be clinically and cost-effective as a primary treatment of open-angle glaucoma (OAG) and ocular hypertension (OHT) at 3 years. ...At 6 years, no s …
PURPOSE: The Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial has shown selective laser trabeculoplasty (SLT) to be clinically …
Neovascular glaucoma - A review.
Senthil S, Dada T, Das T, Kaushik S, Puthuran GV, Philip R, Rani PK, Rao H, Singla S, Vijaya L. Senthil S, et al. Indian J Ophthalmol. 2021 Mar;69(3):525-534. doi: 10.4103/ijo.IJO_1591_20. Indian J Ophthalmol. 2021. PMID: 33595466 Free PMC article. Review.
Neovascular glaucoma (NVG) is a sight-threatening secondary glaucoma characterized by appearance of new vessels over the iris and proliferation of fibrovascular tissue in the anterior chamber angle. ...This review summarizes the causes, pathogenesis, and diff …
Neovascular glaucoma (NVG) is a sight-threatening secondary glaucoma characterized by appearance of new vessels over th …
Approach to childhood glaucoma: A review.
Karaconji T, Zagora S, Grigg JR. Karaconji T, et al. Clin Exp Ophthalmol. 2022 Mar;50(2):232-246. doi: 10.1111/ceo.14039. Epub 2022 Jan 25. Clin Exp Ophthalmol. 2022. PMID: 35023613 Review.
It can be classified as either primary or secondary and the latter may have systemic associations. This review will be based on the work of the childhood glaucoma research network (CGRN) and will focus on the diagnosis and management of the most common types of chil …
It can be classified as either primary or secondary and the latter may have systemic associations. This review will be based on the w …
Acute angle closure glaucoma.
Flores-Sánchez BC, Tatham AJ. Flores-Sánchez BC, et al. Br J Hosp Med (Lond). 2019 Dec 2;80(12):C174-C179. doi: 10.12968/hmed.2019.80.12.C174. Br J Hosp Med (Lond). 2019. PMID: 31822188 Review.
Acute angle closure is an emergent ophthalmic condition that develops as a result of an obstructed outflow of aqueous humour between the anterior and posterior chambers of the eye, leading to a sudden rise in intraocular pressure and secondary optic neuropathy if left untr …
Acute angle closure is an emergent ophthalmic condition that develops as a result of an obstructed outflow of aqueous humour between the ant …
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.
Urbonavičiūtė D, Buteikienė D, Janulevičienė I. Urbonavičiūtė D, et al. Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870. Medicina (Kaunas). 2022. PMID: 36557072 Free PMC article. Review.
Neovascular glaucoma (NVG) is a rare, aggressive, blinding secondary glaucoma, which is characterized by neovascularization of the anterior segment of the eye and leading to elevation of the intraocular pressure (IOP). ...High concentrations of vasogenic subs …
Neovascular glaucoma (NVG) is a rare, aggressive, blinding secondary glaucoma, which is characterized by neovasculariza …
The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy.
Tang Y, Shi Y, Fan Z. Tang Y, et al. Front Endocrinol (Lausanne). 2023 Jan 23;14:1102361. doi: 10.3389/fendo.2023.1102361. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36755912 Free PMC article. Review.
Neovascular glaucoma (NVG) is a devastating secondary glaucoma characterized by the appearance of neovascular over the iris and the proliferation of fibrovascular tissue in the anterior chamber angle. ...The pathogenesis underlying NVG makes it refractory to …
Neovascular glaucoma (NVG) is a devastating secondary glaucoma characterized by the appearance of neovascular over the …
Posner-Schlossman syndrome.
Megaw R, Agarwal PK. Megaw R, et al. Surv Ophthalmol. 2017 May-Jun;62(3):277-285. doi: 10.1016/j.survophthal.2016.12.005. Epub 2016 Dec 22. Surv Ophthalmol. 2017. PMID: 28012873 Review.
Posner-Schlossman syndrome, or glaucomatocyclitic crisis, is a unilateral ocular condition characterized by recurrent attacks of nongranulomatous anterior uveitis and raised intraocular pressure that can result in chronic secondary glaucoma. This relatively rare dis …
Posner-Schlossman syndrome, or glaucomatocyclitic crisis, is a unilateral ocular condition characterized by recurrent attacks of nongranulom …
Diagnosis and treatment of microspherophakia.
Yu X, Chen W, Xu W. Yu X, et al. J Cataract Refract Surg. 2020 Dec;46(12):1674-1679. doi: 10.1097/j.jcrs.0000000000000334. J Cataract Refract Surg. 2020. PMID: 32694307
As a rare congenital disease, microspherophakia (MSP) is characterized by small and spherically shaped crystalline lenses. The common complications of MSP include secondary glaucoma and crystalline lens dislocation or subluxation. ...
As a rare congenital disease, microspherophakia (MSP) is characterized by small and spherically shaped crystalline lenses. The common …
The iridocorneal endothelial syndrome.
Silva L, Najafi A, Suwan Y, Teekhasaenee C, Ritch R. Silva L, et al. Surv Ophthalmol. 2018 Sep-Oct;63(5):665-676. doi: 10.1016/j.survophthal.2018.01.001. Epub 2018 Jan 11. Surv Ophthalmol. 2018. PMID: 29331589 Review.
The iridocorneal endothelial syndrome represents a unique group of ocular pathologies (Chandler syndrome, progressive iris atrophy, and Cogan-Reese syndrome) characterized by the proliferation of corneal endothelial cells that migrate toward the iridocorneal angle and iris surfac …
The iridocorneal endothelial syndrome represents a unique group of ocular pathologies (Chandler syndrome, progressive iris atrophy, and Coga …
1,750 results